Fusion Antibodies plc

Fusion Antibodies plcverified

FAB.L

Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000...[Read more]

Industry

Biotechnology

IPO Date

2017-12-18

Stock Exchange

LSE

Ticker

FAB.L

The Enterprise Value as of December 2025 (TTM) for Fusion Antibodies plc (FAB.L) is 16.14M

According to Fusion Antibodies plc’s latest financial reports and current stock price. The company's current Enterprise Value is 16.14M. This represents a change of 518.34% compared to the average of 2.61M of the last 4 quarters.

Fusion Antibodies plc (FAB.L) Historical Enterprise Value (quarterly & annually)

How has FAB.L Enterprise Value performed in the past?

The mean historical Enterprise Value of Fusion Antibodies plc over the last ten years is 15.83M. The current 16.14M Enterprise Value has changed 10.10% with respect to the historical average. Over the past ten years (40 quarters), FAB.L's Enterprise Value was at its highest in in the September 2020 quarter at 38.73M. The Enterprise Value was at its lowest in in the September 2012 quarter at 0.

Quarterly (TTM)
Annual

Average

15.83M

Median

13.09M

Minimum

982.91K

Maximum

37.51M

Fusion Antibodies plc (FAB.L) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Fusion Antibodies plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 465.43%

Maximum Annual Enterprise Value = 37.51M

Minimum Annual Increase = -90.07%

Minimum Annual Enterprise Value = 982.91K

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20255.56M465.43%
2024982.91K-90.07%
20239.90M-27.17%
202213.59M-63.78%
202137.51M89.18%
202019.83M345.53%
20194.45M-64.65%
201812.59M-53.37%
201727.00M0.48%
201626.87M-1.14%

Fusion Antibodies plc (FAB.L) Average Enterprise Value

How has FAB.L Enterprise Value performed in the past?

The current Enterprise Value of Fusion Antibodies plc (FAB.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

5.48M

5-year avg

13.51M

10-year avg

15.83M

Fusion Antibodies plc (FAB.L) Enterprise Value vs. Peers

How is FAB.L’s Enterprise Value compared to its peers?

Fusion Antibodies plc’s Enterprise Value is greater than Sareum Holdings plc (13.11M), greater than IXICO plc (5.23M), greater than Cambridge Cognition Holdings Plc (14.27M), greater than Genflow Biosciences plc (9.43M), less than Aptamer Group plc (20.25M), greater than Abingdon Health Plc (10.41M), greater than OptiBiotix Health Plc (6.71M), less than Inspiration Healthcare Group plc (31.50M), greater than Futura Medical plc (-3486542.00), greater than Cizzle Biotechnology Holdings Plc (5.98M),

Build a custom stock screener for Fusion Antibodies plc (FAB.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fusion Antibodies plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Fusion Antibodies plc (FAB.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Fusion Antibodies plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Fusion Antibodies plc's Enterprise Value?

What is the highest Enterprise Value for Fusion Antibodies plc (FAB.L)?

What is the 3-year average Enterprise Value for Fusion Antibodies plc (FAB.L)?

What is the 5-year average Enterprise Value for Fusion Antibodies plc (FAB.L)?

How does the current Enterprise Value for Fusion Antibodies plc (FAB.L) compare to its historical average?